View Post

IACS and other platforms develop new cancer treatments for clinical trials

In Clinical Trials by Barbara Jacoby

By: Clayton R. Boldt, Ph.D. From: mdanderson.org Therapeutics Discovery scientists bring clinical cancer research to the lab and use unique model for drug development to benefit cancer patients. “From the bench to the bedside” is a phrase often used to describe a drug discovery’s journey from the laboratory to the clinic, where patients benefit. MD Anderson’s Therapeutics Discovery division, however, …

View Post

Simple drug regimen could help prevent cancer recurrence, Israeli study says

In In The News by Barbara Jacoby

By: Shoshanna Solomon From: timesofisrael.com Combining a stress-reducing drug with an anti-inflammatory helps reduce metastasis of cancer cells, researchers find Israeli researchers said they may have found a way to reduce the risk of post-surgical cancer recurrence through the use of a drug regimen that includes the combination of two drugs that relieve stress and inflammation and have been on …

New therapy strategy for breast cancer that has spread to the brain

In In The News by Barbara Jacoby

Kathy Boltz, PhD Cellular therapy and gene therapy have been successfully combined in a mouse model to develop a viable treatment strategy for breast cancer that has spread to a patient’s brain. Breast cancer is the most common form of cancer in women, and metastasis is a major cause of health deterioration and death from the disease. Managing metastasis is …